Global Oncolytic Virus Market 2020 by Manufacturers, Type and Application, Forecast to 2025

  • receipt Report ID : 67597
  • calendar_today Published On: Sep, 2020
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Market Overview

The Oncolytic Virus market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Oncolytic Virus market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.5%% in the forecast period of 2020 to 2025 and will expected to reach USD 21 million by 2025, from USD 16 million in 2019.

Market segmentation

Oncolytic Virus market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Oncolytic Virus market has been segmented into Imlygic, Oncorine, Others, etc.

Breakdown by Application, Oncolytic Virus has been segmented into Melanoma, Other Cancers, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Oncolytic Virus market presented in the report. This section sheds light on the sales growth of different regional and country-level Oncolytic Virus markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oncolytic Virus market.

For Japan, this report analyses the Japan market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Oncolytic Virus Market Share Analysis

Oncolytic Virus competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Oncolytic Virus sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oncolytic Virus sales, revenue and market share for each player covered in this report.

The major players covered in Oncolytic Virus are: Amgen, SillaJen Biotherapeutics, Transgene SA, Oncolytics Biotech, PsiOxus Therapeutics, Viralytics, Lokon Pharma, Targovax, Oncolys BioPharma, Sorrento Therapeutics, Genelux Corporation, Cold Genesys, Vyriad, TILT Biotherapeutics, etc. Among other players domestic and global, Oncolytic Virus market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The key market players for global Oncolytic Virus market are listed below:

Amgen

SillaJen Biotherapeutics

Transgene SA

Oncolytics Biotech

PsiOxus Therapeutics

Viralytics

Lokon Pharma

Targovax

Oncolys BioPharma

Sorrento Therapeutics

Genelux Corporation

Cold Genesys

Vyriad

TILT Biotherapeutics

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina)

Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)

Market segment by Type, covers:

Imlygic

Oncorine

Others

Market segment by Application, can be divided into

Melanoma

Other Cancers

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Oncolytic Virus Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Oncolytic Virus Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Imlygic

1.2.3 Oncorine

1.2.4 Others

1.3 Market Analysis by Application

1.3.1 Overview: Global Oncolytic Virus Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Melanoma

1.3.3 Other Cancers

1.4 Global Oncolytic Virus Market Size and Forecast (2015-2025)

1.4.1 Global Oncolytic Virus Revenue and Forecast (2015-2025)

1.4.2 Global Oncolytic Virus Sales and Forecast (2015-2025)

1.5 Global Oncolytic Virus Market Size Overview by Geography (2015-2020)

2 Manufacturers Profiles

2.1 Amgen

2.1.1 Amgen Details

2.1.2 Amgen Major Business

2.1.3 Amgen SWOT Analysis

2.1.4 Amgen Product and Services

2.1.5 Amgen Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.2 SillaJen Biotherapeutics

2.2.1 SillaJen Biotherapeutics Details

2.2.2 SillaJen Biotherapeutics Major Business

2.2.3 SillaJen Biotherapeutics SWOT Analysis

2.2.4 SillaJen Biotherapeutics Product and Services

2.2.5 SillaJen Biotherapeutics Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.3 Transgene SA

2.3.1 Transgene SA Details

2.3.2 Transgene SA Major Business

2.3.3 Transgene SA SWOT Analysis

2.3.4 Transgene SA Product and Services

2.3.5 Transgene SA Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.4 Oncolytics Biotech

2.4.1 Oncolytics Biotech Details

2.4.2 Oncolytics Biotech Major Business

2.4.3 Oncolytics Biotech SWOT Analysis

2.4.4 Oncolytics Biotech Product and Services

2.4.5 Oncolytics Biotech Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.5 PsiOxus Therapeutics

2.5.1 PsiOxus Therapeutics Details

2.5.2 PsiOxus Therapeutics Major Business

2.5.3 PsiOxus Therapeutics SWOT Analysis

2.5.4 PsiOxus Therapeutics Product and Services

2.5.5 PsiOxus Therapeutics Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.6 Viralytics

2.6.1 Viralytics Details

2.6.2 Viralytics Major Business

2.6.3 Viralytics Product and Services

2.6.4 Viralytics Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.7 Lokon Pharma

2.7.1 Lokon Pharma Details

2.7.2 Lokon Pharma Major Business

2.7.3 Lokon Pharma Product and Services

2.7.4 Lokon Pharma Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.8 Targovax

2.8.1 Targovax Details

2.8.2 Targovax Major Business

2.8.3 Targovax Product and Services

2.8.4 Targovax Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.9 Oncolys BioPharma

2.9.1 Oncolys BioPharma Details

2.9.2 Oncolys BioPharma Major Business

2.9.3 Oncolys BioPharma Product and Services

2.9.4 Oncolys BioPharma Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.10 Sorrento Therapeutics

2.10.1 Sorrento Therapeutics Details

2.10.2 Sorrento Therapeutics Major Business

2.10.3 Sorrento Therapeutics Product and Services

2.10.4 Sorrento Therapeutics Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.11 Genelux Corporation

2.11.1 Genelux Corporation Details

2.11.2 Genelux Corporation Major Business

2.11.3 Genelux Corporation Product and Services

2.11.4 Genelux Corporation Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.12 Cold Genesys

2.12.1 Cold Genesys Details

2.12.2 Cold Genesys Major Business

2.12.3 Cold Genesys Product and Services

2.12.4 Cold Genesys Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.13 Vyriad

2.13.1 Vyriad Details

2.13.2 Vyriad Major Business

2.13.3 Vyriad Product and Services

2.13.4 Vyriad Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.14 TILT Biotherapeutics

2.14.1 TILT Biotherapeutics Details

2.14.2 TILT Biotherapeutics Major Business

2.14.3 TILT Biotherapeutics Product and Services

2.14.4 TILT Biotherapeutics Oncolytic Virus Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 Global Oncolytic Virus Market, Company Landscape

3.1 Company Market Share Analysis: Global

3.1.1 Global Oncolytic Virus Sales and Market Share by Manufacturer (2018-2019)

3.1.2 Global Oncolytic Virus Revenue and Market Share by Manufacturer (2018-2019)

3.2 Company Market Share Analysis: Japan

3.2.1 Key Players Oncolytic Virus Sales in Japan (2018-2019)

3.2.2 Japan Oncolytic Virus Revenue Market Share by Manufacturer (2018-2019)

3.3 Market Concentration Rate

3.3.1 Top 3 Oncolytic Virus Manufacturer Market Share in 2019

3.3.2 Top 6 Oncolytic Virus Manufacturer Market Share in 2019

4 Market Size by Geography

4.1 Global Oncolytic Virus Market Size by Geography (2015-2020)

4.1.1 Global Oncolytic Virus Sales by Geography (2015-2020)

4.1.2 Global Oncolytic Virus Revenue by Regions (2015-2020)

4.2 Global Oncolytic Virus Market Size and Forecast by Regions (2020-2025)

4.2.1 Global Oncolytic Virus Sales and Forecast by Regions (2020-2025)

4.2.2 Global Oncolytic Virus Revenue and Forecast by Regions (2020-2025)

4.3 North America Oncolytic Virus Market Size and Forecast (2015-2025)

4.4 Europe Oncolytic Virus Market Size and Forecast (2015-2025)

4.5 Asia-Pacific Oncolytic Virus Market Size and Forecast (2015-2025)

4.6 South America Oncolytic Virus Market Size and Forecast (2015-2025)

4.7 Middle East and Africa Oncolytic Virus Market Size and Forecast (2015-2025)

5 North America by Country

5.1 North America Oncolytic Virus Market Size by Country (2015-2020)

5.1.1 North America Oncolytic Virus Sales and Market Share by Country (2015-2020)

5.1.2 North America Oncolytic Virus Revenue and Market Share by Country (2015-2020)

5.2 North America Oncolytic Virus Market Size and Forecast by Country (2020-2025)

5.2.1 North America Oncolytic Virus Sales and Forecast by Country (2020-2025)

5.2.2 North America Oncolytic Virus Revenue and Forecast by Country (2020-2025)

5.3 United States Oncolytic Virus Market Size and Forecast (2015-2025)

5.4 Canada Oncolytic Virus Market Size and Forecast (2015-2025)

5.5 Mexico Oncolytic Virus Market Size and Forecast (2015-2025)

6 Europe by Country

6.1 Europe Oncolytic Virus Market Size by Country (2015-2020)

6.1.1 Europe Oncolytic Virus Sales by Country (2015-2020)

6.1.2 Europe Oncolytic Virus Revenue by Country (2015-2020)

6.2 Europe Oncolytic Virus Market Size and Forecast by Country (2020-2025)

6.2.1 Europe Oncolytic Virus Sales and Forecast by Country (2020-2025)

6.2.2 Europe Oncolytic Virus Revenue and Forecast by Country (2020-2025)

6.3 Germany Oncolytic Virus Market Size and Forecast (2015-2025)

6.4 United Kingdom Oncolytic Virus Market Size and Forecast (2015-2025)

6.5 France Oncolytic Virus Market Size and Forecast (2015-2025)

6.6 Russia Oncolytic Virus Market Size and Forecast (2015-2025)

6.7 Italy Oncolytic Virus Market Size and Forecast (2015-2025)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Oncolytic Virus Market Size by Region (2015-2020)

7.1.1 Asia-Pacific Oncolytic Virus Sales by Region (2015-2020)

7.1.2 Asia-Pacific Oncolytic Virus Revenue by Region (2015-2020)

7.2 Asia-Pacific Oncolytic Virus Market Size and Forecast by Region (2020-2025)

7.2.1 Asia-Pacific Oncolytic Virus Sales and Forecast by Region (2020-2025)

7.2.2 Asia-Pacific Oncolytic Virus Revenue and Forecast by Region (2020-2025)

7.3 China Oncolytic Virus Market Size and Forecast (2015-2025)

7.4 Japan Oncolytic Virus Market Size and Forecast (2015-2025)

7.5 Korea Oncolytic Virus Market Size and Forecast (2015-2025)

7.6 India Oncolytic Virus Market Size and Forecast (2015-2025)

7.7 Southeast Asia Oncolytic Virus Market Size and Forecast (2015-2025)

7.8 Australia Oncolytic Virus Market Size and Forecast (2015-2025)

8 South America by Country

8.1 South America Oncolytic Virus Market Size by Country (2015-2020)

8.1.1 South America Oncolytic Virus Sales by Country (2015-2020)

8.1.2 South America Oncolytic Virus Revenue by Country (2015-2020)

8.2 South America Oncolytic Virus Market Size and Forecast by Country (2020-2025)

8.2.1 South America Oncolytic Virus Sales and Forecast by Country (2020-2025)

8.2.2 South America Oncolytic Virus Revenue and Forecast by Country (2020-2025)

8.3 Brazil Oncolytic Virus Market Size and Forecast (2015-2025)

8.4 Argentina Oncolytic Virus Market Size and Forecast (2015-2025)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Oncolytic Virus Market Size by Country (2015-2020)

9.1.1 Middle East & Africa Oncolytic Virus Sales by Country (2015-2020)

9.1.2 Middle East & Africa Oncolytic Virus Revenue by Country (2015-2020)

9.2 Middle East & Africa Oncolytic Virus Market Size and Forecast by Country (2020-2025)

9.2.1 Middle East & Africa Oncolytic Virus Sales and Forecast by Country (2020-2025)

9.2.2 Middle East & Africa Oncolytic Virus Revenue and Forecast by Country (2020-2025)

9.3 Saudi Arabia Oncolytic Virus Market Size and Forecast (2015-2025)

9.4 Turkey Oncolytic Virus Market Size and Forecast (2015-2025)

9.5 Egypt Oncolytic Virus Market Size and Forecast (2015-2025)

9.6 South Africa Oncolytic Virus Market Size and Forecast (2015-2025)

10 Market Segment by Type

10.1 Global Oncolytic Virus Market Size by Type (2015-2020)

10.1.1 Global Oncolytic Virus Sales by Type (2015-2020)

10.1.2 Global Oncolytic Virus Revenue by Type (2015-2020)

10.1.3 Global Oncolytic Virus Price by Type (2015-2020)

10.2 Global Oncolytic Virus Market Size and Forecast by Type (2020-2025)

10.2.1 Global Oncolytic Virus Sales and Forecast by Type (2020-2025)

10.2.2 Global Oncolytic Virus Revenue and Forecast by Type (2020-2025)

10.2.3 Global Oncolytic Virus Price and Forecast by Type (2020-2025)

10.3 Japan Oncolytic Virus Market Size and Forecast by Type (2015-2025)

10.3.1 Japan Oncolytic Virus Market Size by Type (2015-2020)

10.3.2 Japan Oncolytic Virus Market Size and Forecast by Type (2020-2025)

11 Market Segment by Application

11.1 Global Oncolytic Virus Market Size by Application (2015-2020)

11.1.1 Global Oncolytic Virus Sales by Application (2015-2020)

11.1.2 Global Oncolytic Virus Revenue by Application (2015-2020)

11.1.3 Global Oncolytic Virus Price by Application (2015-2020)

11.2 Global Oncolytic Virus Market Size and Forecast by Application (2020-2025)

11.2.1 Global Oncolytic Virus Sales and Forecast by Application (2020-2025)

11.2.2 Global Oncolytic Virus Revenue and Forecast by Application (2020-2025)

11.2.3 Global Oncolytic Virus Price and Forecast by Application (2020-2025)

11.3 Japan Oncolytic Virus Market Size and Forecast by Application (2015-2025)

11.3.1 Japan Oncolytic Virus Market Size by Application (2015-2020)

11.3.2 Japan Oncolytic Virus Market Size and Forecast by Application (2020-2025)

12 Sales Channel, Distributors, Costumers, and Market Dynamics

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Distributors, Traders and Dealers

12.4.1 Market Opportunities

12.4.2 Market Risk

12.4.3 Market Driving Force

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US

List of Tables

Table 1. Global Oncolytic Virus Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Oncolytic Virus by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Oncolytic Virus Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Oncolytic Virus Market Size Overview by Geography (2015-2020) (USD Million)

Table 5. Global Oncolytic Virus Market Size and Growth Estimation in Various Scenarios in 2020

Table 6. Amgen Basic Information, Manufacturing Base and Competitors

Table 7. Amgen Oncolytic Virus Major Business

Table 8. Amgen Oncolytic Virus Total Revenue (USD Million) (2018-2019)

Table 9. Amgen SWOT Analysis

Table 10. Amgen Oncolytic Virus Product and Services

Table 11. Amgen Oncolytic Virus Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 12. SillaJen Biotherapeutics Basic Information, Manufacturing Base and Competitors

Table 13. SillaJen Biotherapeutics Oncolytic Virus Major Business

Table 14. SillaJen Biotherapeutics Oncolytic Virus Total Revenue (USD Million) (2018-2019)

Table 15. SillaJen Biotherapeutics SWOT Analysis

Table 16. SillaJen Biotherapeutics Oncolytic Virus Product and Services

Table 17. SillaJen Biotherapeutics Oncolytic Virus Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 18. Transgene SA Basic Information, Manufacturing Base and Competitors

Table 19. Transgene SA Oncolytic Virus Major Business

Table 20. Transgene SA Oncolytic Virus Total Revenue (USD Million) (2018-2019)

Table 21. Transgene SA SWOT Analysis

Table 22. Transgene SA Oncolytic Virus Product and Services

Table 23. Transgene SA Oncolytic Virus Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 24. Oncolytics Biotech Basic Information, Manufacturing Base and Competitors

Table 25. Oncolytics Biotech Oncolytic Virus Major Business

Table 26. Oncolytics Biotech Oncolytic Virus Total Revenue (USD Million) (2018-2019)

Table 27. Oncolytics Biotech SWOT Analysis

Table 28. Oncolytics Biotech Oncolytic Virus Product and Services

Table 29. Oncolytics Biotech Oncolytic Virus Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 30. PsiOxus Therapeutics Basic Information, Manufacturing Base and Competitors

Table 31. PsiOxus Therapeutics Oncolytic Virus Major Business

Table 32. PsiOxus Therapeutics Oncolytic Virus Total Revenue (USD Million) (2018-2019)

Table 33. PsiOxus Therapeutics SWOT Analysis

Table 34. PsiOxus Therapeutics Oncolytic Virus Product and Services

Table 35. PsiOxus Therapeutics Oncolytic Virus Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 36. Viralytics Basic Information, Manufacturing Base and Competitors

Table 37. Viralytics Oncolytic Virus Major Business

Table 38. Viralytics Oncolytic Virus Total Revenue (USD Million) (2018-2019)

Table 39. Viralytics SWOT Analysis

Table 40. Viralytics Oncolytic Virus Product and Services

Table 41. Viralytics Oncolytic Virus Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 42. Lokon Pharma Basic Information, Manufacturing Base and Competitors

Table 43. Lokon Pharma Oncolytic Virus Major Business

Table 44. Lokon Pharma Oncolytic Virus Total Revenue (USD Million) (2018-2019)

Table 45. Lokon Pharma SWOT Analysis

Table 46. Lokon Pharma Oncolytic Virus Product and Services

Table 47. Lokon Pharma Oncolytic Virus Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 48. Targovax Basic Information, Manufacturing Base and Competitors

Table 49. Targovax Oncolytic Virus Major Business

Table 50. Targovax Oncolytic Virus Total Revenue (USD Million) (2018-2019)

Table 51. Targovax SWOT Analysis

Table 52. Targovax Oncolytic Virus Product and Services

Table 53. Targovax Oncolytic Virus Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 54. Oncolys BioPharma Basic Information, Manufacturing Base and Competitors

Table 55. Oncolys BioPharma Oncolytic Virus Major Business

Table 56. Oncolys BioPharma Oncolytic Virus Total Revenue (USD Million) (2018-2019)

Table 57. Oncolys BioPharma SWOT Analysis

Table 58. Oncolys BioPharma Oncolytic Virus Product and Services

Table 59. Oncolys BioPharma Oncolytic Virus Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 60. Sorrento Therapeutics Basic Information, Manufacturing Base and Competitors

Table 61. Sorrento Therapeutics Oncolytic Virus Major Business

Table 62. Sorrento Therapeutics Oncolytic Virus Total Revenue (USD Million) (2018-2019)

Table 63. Sorrento Therapeutics SWOT Analysis

Table 64. Sorrento Therapeutics Oncolytic Virus Product and Services

Table 65. Sorrento Therapeutics Oncolytic Virus Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 66. Genelux Corporation Basic Information, Manufacturing Base and Competitors

Table 67. Genelux Corporation Oncolytic Virus Major Business

Table 68. Genelux Corporation Oncolytic Virus Total Revenue (USD Million) (2018-2019)

Table 69. Genelux Corporation SWOT Analysis

Table 70. Genelux Corporation Oncolytic Virus Product and Services

Table 71. Genelux Corporation Oncolytic Virus Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 72. Cold Genesys Basic Information, Manufacturing Base and Competitors

Table 73. Cold Genesys Oncolytic Virus Major Business

Table 74. Cold Genesys Oncolytic Virus Total Revenue (USD Million) (2018-2019)

Table 75. Cold Genesys SWOT Analysis

Table 76. Cold Genesys Oncolytic Virus Product and Services

Table 77. Cold Genesys Oncolytic Virus Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 78. Vyriad Basic Information, Manufacturing Base and Competitors

Table 79. Vyriad Oncolytic Virus Major Business

Table 80. Vyriad Oncolytic Virus Total Revenue (USD Million) (2018-2019)

Table 81. Vyriad SWOT Analysis

Table 82. Vyriad Oncolytic Virus Product and Services

Table 83. Vyriad Oncolytic Virus Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 84. TILT Biotherapeutics Basic Information, Manufacturing Base and Competitors

Table 85. TILT Biotherapeutics Oncolytic Virus Major Business

Table 86. TILT Biotherapeutics Oncolytic Virus Total Revenue (USD Million) (2018-2019)

Table 87. TILT Biotherapeutics SWOT Analysis

Table 88. TILT Biotherapeutics Oncolytic Virus Product and Services

Table 89. TILT Biotherapeutics Oncolytic Virus Sales (K Units), Price (US$/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 90. Global Oncolytic Virus Sales by Manufacturer (2018-2019) (K Units)

Table 91. Global Oncolytic Virus Revenue by Manufacturer (2018-2019) (USD Million)

Table 92. Key Players Oncolytic Virus Sales in Japan (2018-2019) (K Units)

Table 93. Key Players Oncolytic Virus Sales Market Share in Japan (2018-2019)

Table 94. Key Players Revenue of Oncolytic Virus in Japan (2018-2019) (USD Million)

Table 95. Global Oncolytic Virus Sales by Regions (2015-2020) (K Units)

Table 96. Global Oncolytic Virus Sales Market Share by Regions (2015-2020)

Table 97. Global Oncolytic Virus Revenue by Regions (2015-2020) (USD Million)

Table 98. Global Oncolytic Virus Sales and Forecast by Regions (2020-2025) (K Units)

Table 99. Global Oncolytic Virus Sales Market Share by Regions (2020-2025)

Table 100. Global Oncolytic Virus Revenue and Forecast by Regions (2020-2025) (USD Million)

Table 101. Global Oncolytic Virus Revenue Market Share by Regions (2020-2025) (USD Million)

Table 102. North America Oncolytic Virus Sales by Countries (2015-2020) (K Units)

Table 103. North America Oncolytic Virus Sales Market Share by Countries (2015-2020)

Table 104. North America Oncolytic Virus Revenue by Countries (2015-2020) (USD Million)

Table 105. North America Oncolytic Virus Revenue Market Share by Countries (2015-2020)

Table 106. North America Oncolytic Virus Sales by Country (2020-2025) (K Units)

Table 107. North America Oncolytic Virus Sales Market Share by Country (2020-2025)

Table 108. North America Oncolytic Virus Revenue by Country (2020-2025) (USD Million)

Table 109. North America Oncolytic Virus Revenue Market Share by Country (2020-2025)

Table 110. Europe Oncolytic Virus Sales by Countries (2015-2020) (K Units)

Table 111. Europe Oncolytic Virus Sales Market Share by Countries (2015-2020)

Table 112. Europe Oncolytic Virus Revenue by Countries (2015-2020) (USD Million)

Table 113. Europe Oncolytic Virus Revenue Market Share by Countries (2015-2020)

Table 114. Europe Oncolytic Virus Sales by Country (2020-2025) (K Units)

Table 115. Europe Oncolytic Virus Sales Market Share by Country (2020-2025)

Table 116. Europe Oncolytic Virus Revenue by Country (2020-2025) (USD Million)

Table 117. Europe Oncolytic Virus Revenue Market Share by Country (2020-2025)

Table 118. Asia-Pacific Oncolytic Virus Sales by Countries (2015-2020) (K Units)

Table 119. Asia-Pacific Oncolytic Virus Sales Market Share by Countries (2015-2020)

Table 120. Asia-Pacific Oncolytic Virus Revenue by Countries (2015-2020) (USD Million)

Table 121. Asia-Pacific Oncolytic Virus Revenue Market Share by Countries (2015-2020)

Table 122. Asia-Pacific Oncolytic Virus Sales by Country (2020-2025) (K Units)

Table 123. Asia-Pacific Oncolytic Virus Sales Market Share by Country (2020-2025)

Table 124. Asia-Pacific Oncolytic Virus Revenue by Country (2020-2025) (USD Million)

Table 125. Asia-Pacific Oncolytic Virus Revenue Market Share by Country (2020-2025)

Table 126. South America Oncolytic Virus Sales by Countries (2015-2020) (K Units)

Table 127. South America Oncolytic Virus Sales Market Share by Countries (2015-2020)

Table 128. South America Oncolytic Virus Revenue by Countries (2015-2020) (USD Million)

Table 129. South America Oncolytic Virus Revenue Market Share by Countries (2015-2020)

Table 130. South America Oncolytic Virus Sales by Country (2020-2025) (K Units)

Table 131. South America Oncolytic Virus Sales Market Share by Country (2020-2025)

Table 132. South America Oncolytic Virus Revenue by Country (2020-2025) (USD Million)

Table 133. South America Oncolytic Virus Revenue Market Share by Country (2020-2025)

Table 134. Middle East & Africa Oncolytic Virus Sales by Countries (2015-2020) (K Units)

Table 135. Middle East & Africa Oncolytic Virus Sales Market Share by Countries (2015-2020)

Table 136. Middle East & Africa Oncolytic Virus Revenue by Countries (2015-2020) (USD Million)

Table 137. Middle East & Africa Oncolytic Virus Revenue Market Share by Countries (2015-2020)

Table 138. Middle East & Africa Oncolytic Virus Sales by Country (2020-2025) (K Units)

Table 139. Middle East & Africa Oncolytic Virus Sales Market Share by Country (2020-2025)

Table 140. Middle East & Africa Oncolytic Virus Revenue by Country (2020-2025) (USD Million)

Table 141. Middle East & Africa Oncolytic Virus Revenue Market Share by Country (2020-2025)

Table 142. Japan Oncolytic Virus Sales by Type (2015-2020) (K Units)

Table 143. Japan Oncolytic Virus Sales Market Share by Type (2015-2020)

Table 144. Japan Oncolytic Virus Revenue by Type (2015-2020) (USD Million)

Table 145. Japan Oncolytic Virus Revenue Market Share by Type (2015-2020)

Table 146. Japan Oncolytic Virus Sales by Type (2020-2025) (K Units)

Table 147. Japan Oncolytic Virus Sales Market Share by Type (2020-2025)

Table 148. Japan Oncolytic Virus Revenue by Type (2020-2025) (USD Million)

Table 149. Japan Oncolytic Virus Revenue Market Share by Type (2020-2025)

Table 150. Global Oncolytic Virus Sales by Application (2015-2020) (K Units)

Table 151. Global Oncolytic Virus Sales Market Share by Application (2015-2020)

Table 152. Global Oncolytic Virus Revenue by Application (2015-2020) (USD Million)

Table 153. Global Oncolytic Virus Revenue Market Share by Application (2015-2020)

Table 154. Global Oncolytic Virus Price by Application (2015-2020) (US$/Unit)

Table 155. Global Oncolytic Virus Sales by Application (2020-2025) (K Units)

Table 156. Global Oncolytic Virus Sales Market Share by Application (2020-2025)

Table 157. Global Oncolytic Virus Revenue by Application (2020-2025) (USD Million)

Table 158. Global Oncolytic Virus Revenue Market Share by Application (2020-2025)

Table 159. Global Oncolytic Virus Price by Application (2020-2025) (US$/Unit)

Table 160. Japan Oncolytic Virus Sales by Application (2015-2020) (K Units)

Table 161. Japan Oncolytic Virus Sales Market Share by Application (2015-2020)

Table 162. Japan Oncolytic Virus Revenue by Application (2015-2020) (USD Million)

Table 163. Japan Oncolytic Virus Revenue Market Share by Application (2015-2020)

Table 164. Japan Oncolytic Virus Sales by Application (2020-2025) (K Units)

Table 165. Japan Oncolytic Virus Sales Market Share by Application (2020-2025)

Table 166. Japan Oncolytic Virus Revenue by Application (2020-2025) (USD Million)

Table 167. Japan Oncolytic Virus Revenue Market Share by Application (2020-2025)

Table 168. Direct Channel Pros & Cons

Table 169. Indirect Channel Pros & Cons

Table 170. Distributors/Traders/ Dealers List

Table 171. Customers of Oncolytic Virus

Table 172. Market Opportunities in Next Few Years

Table 173. Market Risks Analysis

Table 174. Market Drivers

List of Figures

Figure 1. Oncolytic Virus Picture

Figure 2. Global Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 3. Imlygic Picture

Figure 4. Oncorine Picture

Figure 5. Others Picture

Figure 6. Oncolytic Virus Sales Market Share by Application in 2019

Figure 7. Melanoma Picture

Figure 8. Other Cancers Picture

Figure 9. Global Oncolytic Virus Market Status and Outlook (2015-2025) (USD Million)

Figure 10. Global Oncolytic Virus Sales Growth Rate (2015-2025) (K Units)

Figure 11. Global Oncolytic Virus Sales Market Share by Manufacturer in 2019

Figure 12. Global Oncolytic Virus Revenue Market Share by Manufacturer in 2019

Figure 13. Key Players Oncolytic Virus Revenue Market Share in Japan in 2019

Figure 14. Global Top 5 Oncolytic Virus Manufacturer Market Share in 2019

Figure 15. Top 3 Oncolytic Virus Players Market Share in Japan in 2019

Figure 16. Global Oncolytic Virus Revenue Market Share by Regions in 2019

Figure 17. North America Oncolytic Virus Sales YoY Growth (2015-2025) (K Units)

Figure 18. North America Oncolytic Virus Revenue YoY Growth (2015-2025) (USD Million)

Figure 19. Europe Oncolytic Virus Sales YoY Growth (2015-2020) (K Units)

Figure 20. Europe Oncolytic Virus Revenue YoY Growth (2015-2020) (USD Million)

Figure 21. Asia-Pacific Oncolytic Virus Sales YoY Growth (2015-2020) (K Units)

Figure 22. Asia-Pacific Oncolytic Virus Revenue YoY Growth (2015-2020) (USD Million)

Figure 23. South America Oncolytic Virus Sales YoY Growth (2015-2020) (K Units)

Figure 24. South America Oncolytic Virus Revenue YoY Growth (2015-2020) (USD Million)

Figure 25. Middle East & Africa Oncolytic Virus Sales YoY Growth (2015-2020) (K Units)

Figure 26. Middle East & Africa Oncolytic Virus Revenue YoY Growth (2015-2020) (USD Million)

Figure 27. North America Oncolytic Virus Sales Market Share by Country in 2019

Figure 28. North America Oncolytic Virus Revenue Market Share by Country in 2019

Figure 29. United States Oncolytic Virus Market Size and Growth Rate (2015-2025) (USD Million)

Figure 30. Canada Oncolytic Virus Market Size and Growth Rate (2015-2025) (USD Million)

Figure 31. Mexico Oncolytic Virus Market Size and Growth Rate (2015-2020) (USD Million)

Figure 32. Europe Oncolytic Virus Revenue Market Share by Country in 2019

Figure 33. Germany Oncolytic Virus Market Size Growth Rate (2015-2025) (USD Million)

Figure 34. United Kingdom Oncolytic Virus Market Size Growth Rate (2015-2025) (USD Million)

Figure 35. France Oncolytic Virus Market Size Growth Rate (2015-2025) (USD Million)

Figure 36. Russia Oncolytic Virus Market Size Growth Rate (2015-2025) (USD Million)

Figure 37. Italy Oncolytic Virus Market Size Growth Rate (2015-2025) (USD Million)

Figure 38. Asia-Pacific Oncolytic Virus Sales Market Share by Region 2018

Figure 39. Asia-Pacific Oncolytic Virus Revenue Market Share by Region 2018

Figure 40. China Oncolytic Virus Market Size Growth Rate (2015-2025) (USD Million)

Figure 41. Japan Oncolytic Virus Market Size Growth Rate (2015-2025) (USD Million)

Figure 42. Korea Oncolytic Virus Market Size Growth Rate (2015-2025) (USD Million)

Figure 43. India Oncolytic Virus Market Size Growth Rate (2015-2025) (USD Million)

Figure 44. Southeast Asia Oncolytic Virus Market Size Growth Rate (2015-2025) (USD Million)

Figure 45. Australia Oncolytic Virus Market Size Growth Rate (2015-2025) (USD Million)

Figure 46. South America Oncolytic Virus Sales Market Share by Country in 2019

Figure 47. South America Oncolytic Virus Revenue Market Share by Country in 2019

Figure 48. Brazil Oncolytic Virus Market Size Growth Rate (2015-2025) (USD Million)

Figure 49. Argentina Oncolytic Virus Market Size Growth Rate (2015-2025) (USD Million)

Figure 50. Saudi Arabia Oncolytic Virus Market Size Growth Rate (2015-2025) (USD Million)

Figure 51. Turkey Oncolytic Virus Market Size Growth Rate (2015-2025) (USD Million)

Figure 52. Egypt Oncolytic Virus Market Size Growth Rate (2015-2025) (USD Million)

Figure 53. South Africa Oncolytic Virus Market Size Growth Rate (2015-2025) (USD Million)

Figure 54. Global Revenue Market Share of Oncolytic Virus by Type in 2019

Figure 55. Global Revenue Market Share of Oncolytic Virus by Application in 2019

Figure 56. Sales Channel: Direct Channel vs Indirect Channel